Have they been contracted by Painchek to assess the tool? Though I do see source of support and conflict of interest is nil. I just find it strange that this work is published in a journal with a 0.65 impact factor which is very low, not to mention to first author is using a .gmail email address, rather than institutional one. Obviously I'm just as excited as everyone that pck is gaining traction but as something who works in the field I just find it odd.
PainChek General Discussion, page-15235
-
- There are more pages in this discussion • 5,178 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $45.80M | |||
| Open | High | Low | Value | Volume |
| 2.9¢ | 2.9¢ | 2.8¢ | $11.12K | 392.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1419145 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 326044 | 2 |
View Market Depth
| Last trade - 14.23pm 16/07/2024 (20 minute delay) ? |
| PCK (ASX) Chart |